Thiazolidinediones and congestive heart failure-exacerbation or new onset of left ventricular dysfunction?
about
PPARgamma agonists: safety issues in heart failure.Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?Cardiovascular risk of rosiglitazone: another perspective.Comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors: SGLT2 inhibitors in the real world.
P2860
Thiazolidinediones and congestive heart failure-exacerbation or new onset of left ventricular dysfunction?
description
scientific article published on 01 August 2004
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2004
@uk
name
Thiazolidinediones and congest ...... left ventricular dysfunction?
@en
Thiazolidinediones and congest ...... left ventricular dysfunction?
@nl
type
label
Thiazolidinediones and congest ...... left ventricular dysfunction?
@en
Thiazolidinediones and congest ...... left ventricular dysfunction?
@nl
prefLabel
Thiazolidinediones and congest ...... left ventricular dysfunction?
@en
Thiazolidinediones and congest ...... left ventricular dysfunction?
@nl
P2093
P2860
P1433
P1476
Thiazolidinediones and congest ...... left ventricular dysfunction?
@en
P2093
Burrell LM
Calafiore P
MacIsaac RJ
P2860
P304
P356
10.1111/J.1464-5491.2004.01274.X
P577
2004-08-01T00:00:00Z